# EDGAR Filing Document

**Accession Number:** 0001512922
**File Stem:** 0001099910-26-000031
**Filing Date:** 2026-1
**Character Count:** 18941
**Document Hash:** f5399b890ae60d7b39bf93ada3df51ea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001099910-26-000031.hdr.sgml**: 20260116

**ACCESSION NUMBER**: 0001099910-26-000031

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260116

**DATE AS OF CHANGE**: 20260116

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PetVivo Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001512922
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 990363559
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88052
- **FILM NUMBER:** 26539865

**BUSINESS ADDRESS:**
- **STREET 1:** 5251 EDINA INDUSTRIAL BLVD
- **CITY:** EDINA
- **STATE:** MN
- **ZIP:** 55439
- **BUSINESS PHONE:** (952) 217-4952

**MAIL ADDRESS:**
- **STREET 1:** 5251 EDINA INDUSTRIAL BLVD
- **CITY:** EDINA
- **STATE:** MN
- **ZIP:** 55439

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Technologies Scan Corp
- **DATE OF NAME CHANGE:** 20110211
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** A.L. Sarroff Fund, LLC
- **CENTRAL INDEX KEY:** 0001553209

**ORGANIZATION NAME:**
- **EIN:** 455478648
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 43 MEADOW WOODS ROAD
- **CITY:** GREAT NECK
- **STATE:** NY
- **ZIP:** 11020
- **BUSINESS PHONE:** 917-513-4615

**MAIL ADDRESS:**
- **STREET 1:** 43 MEADOW WOODS ROAD
- **CITY:** GREAT NECK
- **STATE:** NY
- **ZIP:** 11020

## Exhibit 99.1

**<u>Exhibit 99.1</u>**

**JOINT FILING AGREEMENT**

This Joint Filing Agreement, dated as of January 16, 2026, is by and among A.L. Sarroff Fund, LLC, Alan Sarroff, and Eileen Sarroff (collectively, the "Filers").

Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to the shares of common stock, with a nominal value of $0.001 per share, of PetVivo Holdings, Inc. beneficially owned by them from time to time.

Pursuant to and in accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13D and/or 13G (and any amendments thereto) on behalf of each of the Filers, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

This Joint Filing Agreement may be terminated by any of the Filers upon written notice or such lesser period of notice as the Filers may mutually agree.

Executed and delivered as of the date first above written.

---

| |
|:---|
| **A.L. Sarroff Fund, LLC** |
|  <br> By: <u>/s/ Alan Sarroff</u> |
| Name: Alan Sarroff |
| Title: Chief Executive Officer and Managing Member |
| **Alan Sarroff** |
|  <br> By: <u>/s/ Alan Sarroff</u> |
| Name: Alan Sarroff |
| **Eileen Sarroff** |
|  <br> By: <u>/s/ Eileen Sarroff</u> |
| Name: Eileen Sarroff<br>|

---

## Exhibit 99.2

**<u>Exhibit 99.2</u>**

**<u>Transactions – Past 60 days</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;Date | &nbsp;&nbsp;Reporting Person | &nbsp;&nbsp;Number | &nbsp;&nbsp;Transaction | &nbsp;&nbsp;Price |
| &nbsp;&nbsp;11/17/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.12 |
| &nbsp;&nbsp;11/17/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;2000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.16 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;2000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.13 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;500 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.12 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;3188 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.08 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;2000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.10 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;500 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.12 |
| &nbsp;&nbsp;11/18/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;2000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.12 |
| &nbsp;&nbsp;11/19/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.09 |
| &nbsp;&nbsp;11/19/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;9060 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.09 |
| &nbsp;&nbsp;11/20/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.10 |
| &nbsp;&nbsp;11/20/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.10 |
| &nbsp;&nbsp;11/21/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;127250 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$0.95 |
| &nbsp;&nbsp;12/02/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;1000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.13 |
| &nbsp;&nbsp;12/05/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;4900 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.12 |
| &nbsp;&nbsp;12/05/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;16671 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.10 |
| &nbsp;&nbsp;12/08/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;8154 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.05 |
| &nbsp;&nbsp;12/09/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;5100 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.11 |
| &nbsp;&nbsp;12/10/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;6700 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.14 |
| &nbsp;&nbsp;12/11/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.17 |
| &nbsp;&nbsp;12/12/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;1100 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.14 |
| &nbsp;&nbsp;12/16/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;7700 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.15 |
| &nbsp;&nbsp;12/24/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;10000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.07 |
| &nbsp;&nbsp;12/24/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;4632 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.13 |
| &nbsp;&nbsp;12/26/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;1000 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.18 |
| &nbsp;&nbsp;12/26/25 | &nbsp;&nbsp;Mrs. Sarroff | &nbsp;&nbsp;1400 | &nbsp;&nbsp;Open Market Purchase | &nbsp;&nbsp;$1.15 |
| &nbsp;&nbsp;12/31/25 | &nbsp;&nbsp;Mr. Sarroff | &nbsp;&nbsp;60000 | &nbsp;&nbsp;Bona Fide Gift (Disposition) | &nbsp;&nbsp;$0.00 |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**PetVivo Holdings, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.001 per share**

*(Title of Class of Securities)*

**716817408**

*(CUSIP Number)*

**Jeffrey J. Fessler, Esq.**<br>30 Rockefeller Plaza<br>New York NY 10112<br>(212) 653-8700

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/01/2024**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **716817408** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**A.L. Sarroff Fund, LLC** | Name of reporting person<br>**A.L. Sarroff Fund, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**NEW YORK** | Citizenship or place of organization<br>**NEW YORK** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**13933204.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**13933204.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**36.1%** | Percent of class represented by amount in Row (11)<br>**36.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

| **CUSIP No.** | **716817408** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Alan Sarroff** | Name of reporting person<br>**Alan Sarroff** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**13933204.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**13933204.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**36.1%** | Percent of class represented by amount in Row (11)<br>**36.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **716817408** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Eileen Sarroff** | Name of reporting person<br>**Eileen Sarroff** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**13933204.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**13933204.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | Aggregate amount beneficially owned by each reporting person<br>**13933204.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**36.1%** | Percent of class represented by amount in Row (11)<br>**36.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.001 per share

**(b) Name of Issuer:**
PetVivo Holdings, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
5251 EDINA INDUSTRIAL BLVD, EDINA, MN, 55439

**Item 4. Purpose of Transaction**

The information set forth in or incorporated by reference in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4.

The Reporting Persons intend to continue to review their investment in the Issuer on a continuing basis, and depending upon various factors, including without limitation, the Issuer's financial position and strategic direction, the outcome of any discussions referenced above, overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor (i) to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through transactions involving the shares common stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer in the open market or in private transactions, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or decrease their economic exposure to the shares of common stock without affecting their beneficial ownership of the shares of common stock or adjust their exposure to the shares of common stock in ways that would affect their beneficial ownership of the shares of common stock.

Except to the extent the foregoing may be deemed a plan or proposal, none of the Reporting Persons has any plans or proposals which relate to, or could result in, any of the matters referred to in subparagraphs (a) - (j) of Item 4 of Schedule 13D. The Reporting Persons may, at any time and from time to time, (i) review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto and (ii) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Persons beneficially own an aggregate of 13,933,204 shares of common stock, which represents approximately 36.1% of the outstanding shares of common stock, based on 33,580,630 shares of common stock outstanding as of November 14, 2025, and assumes the exercise of warrants to purchase 5,005,008 shares of common stock.

**(b)**
See Items 7-11 of the cover pages and Item 5(a) above.

**(c)**
Exhibit 99.2  hereto sets forth all transactions in the common stock by any Reporting Person during the past sixty (60) days. Except for the transactions set forth on Exhibit 99.2, none of the Reporting Persons effected any transaction during the past sixty (60) days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in or incorporated by reference in Items 3, 4, and 5 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 6.

The Reporting Persons may, from time to time, enter into and dispose of swaps, options or other derivative transactions with one or more counterparties that are based upon the value of the common stock, which transactions may be significant in amount. The profit, loss and/or return on such contracts may be wholly or partially dependent on the market value of the common stock.

On January 16, 2026, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Except as set forth herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 hereof and between such persons and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** A.L. Sarroff Fund, LLC

**Signature:** /s/ Alan Sarroff

**Name/Title:** By Alan Sarroff, Chief Executive Officer and Managing Member

**Date:** 01/16/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Alan Sarroff

**Signature:** /s/ Alan Sarroff

**Name/Title:** Alan Sarroff

**Date:** 01/16/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Eileen Sarroff

**Signature:** /s/ Eileen Sarroff

**Name/Title:** Eileen Sarroff

**Date:** 01/16/2026